NeuroPace Inc Ownership
$13.94
1.48%
Nasdaq, Sep 29, 04:00 pm EDT.
Closed.
Index
Industry
NeuroPace Inc Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Accelmed Growth Partners Management Ltd
|
4.433m | 12.93% | — | Apr 09 2026 |
| 2 |
Polar Capital LLP
|
3.298m | 9.62% | +419.581k | Mar 31 2026 |
| 3 |
Soleus Capital Management, L.P.
|
2.932m | 8.55% | +228.999k | Mar 31 2026 |
| 4 |
Morgan Stanley & Co. LLC
|
2.563m | 7.48% | +20.154k | Mar 31 2026 |
| 5 |
First Light Asset Management, LLC
|
2.460m | 7.18% | +1.110m | Mar 31 2026 |
|
1
Accelmed Growth Partners Management Ltd
|
12.93%
4.433m
|
|
2
Polar Capital LLP
|
9.62%
3.298m
|
|
3
Soleus Capital Management, L.P.
|
8.55%
2.932m
|
|
4
Morgan Stanley & Co. LLC
|
7.48%
2.563m
|
|
5
First Light Asset Management, LLC
|
7.18%
2.460m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 45.76% of NeuroPace Inc, with Accelmed Growth Partners Management Ltd the biggest at 12.93%, followed by Polar Capital LLP (9.62%) and Soleus Capital Management, L.P. (8.55%). |
Recent NeuroPace Inc Insider Transactions
Powered by
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Sep 30 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Sep 27 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Sep 23 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Sep 18 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Sep 12 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Sep 05 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Sep 30 2026
$182.45
|
|
Sarah Chen
SALES
|
Sep 27 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Sep 23 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Sep 18 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Sep 12 2026
$170.50
|
|
Lisa Park
SALES
|
Sep 05 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
NeuroPace Inc Short interest
Powered by
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in NeuroPace Inc has fallen over the past 12 months from around 4.8% to 3.2% of the float. Fewer and fewer market participants are betting on falling prices. That points to easing skepticism, as short sellers increasingly unwind their positions. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
